Plain-English translation of NCT07261826 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a large real-world study following up to 4,000 patients who have received fecal microbiota transplantation (FMT)—a procedure where healthy stool bacteria are transferred to patients—to treat various gut and related conditions. Researchers will look at how well this treatment works over 5 years and track any side effects. The goal is to better understand which patients benefit most and how to make this treatment safer and more effective.
Although stool transplants show promise for treating hard-to-manage gut conditions and related disorders, doctors need more long-term data to understand how well this treatment really works in everyday practice, how safe it is over time, and which patients are most likely to benefit.
You likely qualify if…
You likely don't qualify if…
Since this is an observational study, you won't receive new treatment—instead, researchers will review your existing medical records from your stool transplant procedure and follow-up visits to track your progress at 3 months, 1 year, and 5 years after treatment. If you're part of the forward-looking group, you may have scheduled follow-up visits where your health status is checked and your progress is documented.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
China